Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,003 | 0,009 | 16.05. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.05. | Wesana Health Holdings Inc: Wesana Health Holdings halted at the open | 1 | Stockwatch | ||
WESANA HEALTH Aktie jetzt für 0€ handeln | |||||
24.01. | Wesana Health Holdings Inc: Wesana Health appoints Monaghan, Purdy as directors | 1 | Stockwatch | ||
24.01. | Wesana Health Holdings Inc.: Wesana Health Announces Change to The Board of Directors | 746 | Newsfile | Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - January 24, 2025) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTC Pink: WSNAF) (the "Company") is pleased to announce the appointment of Mark... ► Artikel lesen | |
17.10.24 | XFRA DDX: AUSSETZUNG/SUSPENSION | 249 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILWESANA HEALTH HOLD.... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 51,40 | +1,10 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
ESSILORLUXOTTICA | 260,20 | -0,19 % | Dividendenbekanntmachungen (07.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACRINOVA AB SE0015660014 0,4 SEK 0,0367 EUR ACRINOVA AB B SE0015660030 0,4 SEK 0,0367 EUR ANHEUSER-BUSCH INBEV SA/NV ADR US03524A1088 1... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,128 | -3,03 % | Sernova Biotherapeutics Inc: Sernova talks interim data from Cell Pouch trial | ||
ALIGN TECHNOLOGY | 168,20 | -0,38 % | ALGN Stock Might Rise Following the NMPA Approval in China | ||
NUGEN MEDICAL DEVICES | 0,040 | 0,00 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
HEALWELL AI | 0,941 | +0,37 % | HEALWELL meldet Rekord-Umsatzwachstum von 208 % im 1. Quartal 2025, einschließlich Rekordwachstum von 224 % bei KI- und Data-Science-Umsätzen | - HEALWELL erzielte im 1. Quartal 2025 einen Quartalsumsatz aus fortgeführten Geschäftsbereichen in Höhe von 14,1 Millionen $, was einer Steigerung von 208 % gegenüber 4,6
Millionen... ► Artikel lesen | |
INMODE | 13,100 | -0,42 % | DOMA Urges InMode Board To Replace CEO And Resume Share Buybacks Amid Valuation Concerns | ||
INVITAE | - | - | Ex-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding | ||
ATOSSA THERAPEUTICS | 0,861 | -4,86 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
SPINEWAY | 0,120 | 0,00 % | Spineway: First-quarter 2025 revenue of €2.8 million | Press release Ecully, April 16, 2025 - 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated... ► Artikel lesen | |
ELEVANCE HEALTH | 360,60 | -0,30 % | Elevance Health, Inc. - 8-K, Current Report | ||
MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
VERU | 0,456 | -0,31 % | JTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next Level | Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
ONTRAK | 1,550 | -3,73 % | Ontrak verzeichnet signifikante Verluste im letzten Quartal |